Specify a stock or a cryptocurrency in the search bar to get a summary
Captor Therapeutics S.A.
603949Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland. Address: ul. Dunska 11, Wroclaw, Poland, 54-427
Analytics
WallStreet Target Price
393.54 PLNP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603949
Dividend Analytics 603949
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 603949
Stock Valuation 603949
Financials 603949
Results | 2019 | Dynamics |